Get the Stockscreener App
14.53
0.97%
0.14
After Hours:
14.48
-0.05
-0.34%
Caredx Inc stock is traded at $14.53, with a volume of 914.47K.
It is up +0.97% in the last 24 hours and up +7.39% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$14.39
Open:
$14.61
24h Volume:
914.47K
Relative Volume:
0.54
Market Cap:
$773.39M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-5.4015
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-2.87%
1M Performance:
+7.39%
6M Performance:
-22.75%
1Y Performance:
-52.55%
1-Day Range:
$14.34
$14.88
1-Week Range:
$13.95
$15.10
52-Week Range:
$10.96
$31.52
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
14.53 | 765.94M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
What Fibonacci levels say about CareDx Inc reboundJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Analyzing net buyer seller activity in CareDx IncJuly 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com
CareDx Inc’s volatility index tracking explainedSell Signal & Precise Swing Trade Entry Alerts - newser.com
QRG Capital Management Inc. Acquires Shares of 21,801 CareDx, Inc. $CDNA - MarketBeat
What analysts say about CareDx Inc stockPortfolio Allocation Tips & Our Picks = Your Future Gains - earlytimes.in
Analyzing CareDx Inc with risk reward ratio chartsGold Moves & Expert Approved Trade Ideas - newser.com
Price momentum metrics for CareDx Inc explained2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Will CareDx Inc (1K9) stock keep high P E multiples2025 Institutional Moves & Free Daily Entry Point Trade Alerts - newser.com
CareDx (NASDAQ:CDNA) Receives "Sell (D+)" Rating from Weiss Ratings - MarketBeat
Will CareDx Inc stock recover after recent dropLayoff News & Verified Momentum Stock Alerts - newser.com
How high can CareDx Inc stock go2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
CareDx ($CDNA) has reached a settlement with investorsHow to Get Your Payment - TradingView
Gagnon Securities LLC Purchases 127,223 Shares of CareDx, Inc. $CDNA - MarketBeat
Gagnon Advisors LLC Purchases 41,288 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (NASDAQ:CDNA) Receives Average Rating of "Hold" from Analysts - MarketBeat
Law Profs Say CareDx False Ad Verdict Should Stand - Law360
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 Amer - PharmiWeb.com
Why CareDx Inc (1K9) stock fits value portfoliosQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Why global investors buy CareDx Inc (1K9) stockQuarterly Profit Report & Daily Growth Stock Tips - newser.com
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting - BioSpace
CareDx unveils new transplant diagnostics at ASHI 2025 meeting - Investing.com
CareDx unveils new transplant diagnostics at ASHI 2025 meeting By Investing.com - Investing.com Nigeria
at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting - Business Wire
Signal strength of CareDx Inc stock in tech scannersProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Real time social sentiment graph for CareDx Inc2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Applying Wyckoff theory to CareDx Inc stockMarket Trend Report & Growth Oriented Trading Recommendations - newser.com
Using Ichimoku Cloud for CareDx Inc technicals2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com
CareDx (NASDAQ:CDNA) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
CareDx ($CDNA) Is Paying a $20.25M Settlement to Investors — Here’s How to Get Your Share - TradingView
Will CareDx Inc (1K9) stock top growth indexesQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
Can CareDx Inc (1K9) stock attract analyst upgradesPortfolio Performance Summary & Step-by-Step Swing Trade Plans - newser.com
Real time pattern detection on CareDx Inc stockEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Novack Jeffrey Adam | Secretary and General Counsel |
Aug 05 '25 |
Sale |
12.79 |
2,688 |
34,381 |
112,930 |
1.61%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):